31,695 Shares in Amicus Therapeutics, Inc. (NASDAQ:FOLD) Purchased by Aigen Investment Management LP
Aigen Investment Management LP bought a new position in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) during the third quarter, Holdings Channel reports. The fund bought 31,695 shares of the biopharmaceutical company’s stock, valued at approximately $385,000. A number of other institutional investors also recently bought and sold shares of the company. Vanguard […]
More Stories
Andre Agassi Wins His Professional Pickleball Debut With Partner Anna Leigh Waters
By The Associated Press NAPLES, Fla.—Andre Agassi won his professional pickleball debut a day after turning 55, teaming with 18-year-old...
Market Review: Stocks Retreat on Fed Caution and Trade Uncertainty
By Panos Mourdoukoutas U.S. stocks edged slightly lower this week, ending a nine-day winning streak that pushed the S&P 500...
India and Pakistan Agree to US-Mediated Cease-Fire
By Andrew Thornebrooke India and Pakistan have agreed to the terms of a U.S.-mediated cease-fire following three days of cross-border...
FDA Approves 3 Natural Color Additives Amid Push to Remove Artificial Food Coloring
By Bill Pan The U.S. Food and Drug Administration (FDA) has approved three color additives derived from natural sources for...
Google to Pay $1.4 Billion to Texas, Settle Data Privacy Case
By Naveen Athrappully Google has agreed to settle multiple data privacy lawsuits brought by Texas Attorney General (AG) Ken Paxton...
Ukraine and Allies Call on Russia to Accept US Cease-Fire Proposal
By Andrew Thornebrooke Ukraine and its international partners are calling on Russia to accept a U.S. proposal for a “full,...